L. Le

Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors

K. Papadopoulos, G. Falchook, Judy S. Wang, 2020, Cancer Immunology, Immunotherapy.

Analysis for clinical efficacy and virological evolution during sequential entecavir plus adefovir combination and tenofovir ± entecavir therapies in entecavir-resistant chronic hepatitis B patients

Liu Yan, Zhou Yi, Chen Rong-juan, 2018 .

A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer.

T. Stockley, E. Chen, D. Graham, 2021, Lung cancer.